Skip to main content
. 2021 Mar;42(3):457–463. doi: 10.3174/ajnr.A6931

FIG 5.

FIG 5.

A 62-year-old woman with ring (①, ≥5 mm, arrow) and solid (②, ≥5 mm, arrowhead) enhancing brain metastases. A, Nonenhanced T2 FLAIR. B, Phase 3 half-dose CE-T2 FLAIR (①, 3 points; ②, missed diagnosis). C, Half-dose CE-T1WI (①, 1 point; ②, 3 points). D, Routine-dose CE-BRAVO (①, 2 points; ②, 3 points).